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The „in vivo” experiment has had as aim the study of different Cr(VI) doses 
administration on globular resistance in female rats related to administration 
duration. Study was carried out on 56 female rats divided in 8 groups, 6 
experimental  and 2 control that received potassium dichromate in drinking water 
in doses of 25 ppm, 50 ppm and 75ppm Cr(VI), for 3 months, respectively, 6 
months. Decrease of globular resistance (in terms of haemolysis degree in 
hypotonic solutions) at increasing dose (up to 0.8% NaCl at 75 ppm dose) in all 
experimental groups, in direct relation with the duration of administration was 
registered. Control groups were in physiological limits. The results of the present 
study revealed the affecting of erythrocyte membrane in function of administration 
duration  and chromium intake level, because of oxidative lesions produced by it. 
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Introduction 
 
The „in vivo” experiment has had as aim the study of different Cr(VI) 
doses administration on globular resistance in female rats related to administration 
duration 
Materials and Methods 
 
Researches were carried out on 56 female Wistar rats divided into 8 groups 
of 7 individuals (6 experimental groups: E1, E2, E3, E4, E5, E6 and 2 control groups 
C1 and C2). 
Potassium dichromate (Cr VI) in experimental groups was administered in 
drinking water. The E1, E2 and E3 groups received for 3 months the doses of 25   623
ppm, 50 ppm and 75 ppm, and E4, E5 and E6, groups, doses of 25, 50 and 
respectively, 75 ppm for 6 months. 
Haemoglobin (Hb) and globular resistance (in terms of the haemolysis 
degree in hypotonic solutions) were determined Drabkin by spectrophotometric 
method (UV-VIS spectrophotometer Shimadzu, λ = 540 nm). 
 
Results and Discussion 
 
   The mean values of the studied parameters are presented in tables 1, 2 and 3. 
 
Table 1 
The erythrocyte membrane haemolysis degree, depending on the Cr (VI) dose and 
duration of administration 
% 
NaCl 
3 months  6 months 
 E 1  E2 E 3 C 1 E 4 E 5 E 6 C 2 
0 100 100  100  100 100 100  100  100 
0.3 93.2± 
0.56 
95.11± 
0.41 
97.98± 
0.94 
83.46± 
2.79 
97.72± 
0.51 
98.86± 
1.02 
99.2± 
0.55 
85.96± 
0.22 
0.35 87.74± 
1.59 
93.22± 
1.49 
93.47± 
2.14 
59.2± 
2.04 
93.09± 
1.11 
97.34± 
1.56 
98.52± 
1.15 
61.42± 
0.95 
0.4 81.69± 
2.94 
87.09± 
2.26  
88.38± 
4.10.89 
29.29± 
2.42 
89.29± 
2.04 
92.99± 
1.44 
95.91± 
1.28 
30.29± 
1.28 
0.45 49.22± 
3.28 
51.22± 
3.19 
72.36± 
4.21 
7.70± 
2.76 
58.73± 
2.47 
70.07± 
3.19 
75.18± 
3.94 
8.08± 
2.07 
0.5 14.91± 
1.25 
15.33± 
1.08 
29.49± 
0.86 
1.02± 
0.68 
23.14± 
0.85 
24.99± 
1.62 
25.73± 
1.37 
2.12± 
1.62 
0.55 5.69± 
0.12 
5.83± 
0.4 
10.4± 
1.04 
0.1± 
0.02 
6.39± 
0.88 
6.17± 
0.87 
13.45± 
1.38 
0.75± 
0.03 
0.6 4.76± 
0.2 
4.82± 
0.29 
5.05± 
0.58 
0 4.7± 
0.24 
5.51± 
0.4 
7.15± 
0.46 
0 
0.65 3.85± 
0.16 
3.84± 
0.44 
3.89± 
0.58 
0 3.7± 
0.32 
3.80± 
0.22 
3.97± 
0.55 
0 
0.7 1.8± 
0.15 
2.45± 
0.2 
2.99± 
0.31 
0 2.07± 
0.25 
2.76± 
0.14 
3.35± 
0.3 
0 
0.75 0 1.06± 
0.07 
2.44± 
0.15 
0 0  1.36± 
0.2 
3.08± 
0.25 
0 
0.8  0  0 2.07±0.21 0  0  0 2.44±0.2 0 
 
Administration of the three levels of Cr (VI) over a period of 3 and 6 
months, determined decrease of globular resistance (in terms of haemolysis degree 
in hypotonic solutions) in direct relationship with the dose in all experimental 
groups (E1 and E4  at 0.7% NaCl, E 2 and E5 at 0.75% NaCl, E3 and E6 in 0.8% 
NaCl) (table 1), and comparative to control and to literature data as physiological 
(Ghergariu, 2000)   624
Table 2 
Maximum and minimum globular resistance in experimental and control groups 
Globular resistance  E1 E2 E 3 C 1 E 4 E 5 E 6 C 2 
max.%  NaCl  100 100 100 100 100 100 100 100 
min.%  NaCl  0.7 0.75 0.8 0.55 0.7 0.75 0.8 0.55 
 
Maximum globular resistance (table 2) was the same in all experimental 
and control groups, ranging in the physiological values (Ghergariu, 2000, 
Meingassner, 1992). Note that increasing duration of administration, at the same 
dose, the same minimum globular resistance was recorded. Increasing the duration 
of administration, however,  haemolysis degree increased (table1) (E4/E1:+13.05%; 
E5/E2:+22.06%; E6/E3:+15.17%). 
Chromium may have serious enough adverse effects (Baghi, 2002, 
Kirpnic-Sobol, 2006). Hexavalent chromium ions entered into the body are 
reduced by intracellular mechanisms insufficiently known. Molecular mechanisms 
of intracellular reduction of Cr(VI), to Cr(V), Cr(IV) and Cr(III), are generators of 
reactive oxygen species (Luca, 2007). During the reduction of Cr (VI), are formed 
intermediate reactives, such as hydroxyl radicals that can cause oxidative damage 
of lipids (Al_Mustafa, 2006), proteins and nucleic acids, a process that causes the 
appearence of a stress state. In cell, intermediate products as free radicals, increase 
oxidative stress (Chundawat, 2004, Dejica, 2000). Cr (VI) citotoxicity mechanism 
is not completely known. A large number of studies revealed that Cr(VI) induces 
oxidative stress (Baghi, 2002, Dejica, 2000). “In vitro” studies regarding 
citotoxicity of a soluble compound of hexavalent chromium have relieved some 
impairment of antioxygen defence system and appearing of lipids peroxidation as 
type of oxidative lesion, which affects cell integrity (Baghi, 2002). 
The experiment revealed that high doses of Cr(VI) and long-term of 
administration, as oxidative damage that may occur, are affecting the erythrocyte 
membrane  and may induce haemolytic effect. 
Table 3 
Dynamic of average values of haemoglobin in experimental and control groups 
Hb 
g/dl 
d s x   
E1  E2 E 3 C 1 E 4 E 5 E 6 C 2 
14.08± 
0.22 
13.16± 
0.45 
11.64± 
0.12 
14.72± 
0.19 
12.58± 
0.18 
12.06± 
0.35 
9.62± 
0.44 
14.88± 
0.22 
 
The obtained results concerning haemoglobin dynamics pointed out that 
the level and duration of chromium intake had induced significant decrease                     
(p <0.05) of Hb values in E1 group and high significant (p <0.01) in the other 
experimental groups compared to control (E1/M:-4.35%; E2/M: -10.66%; E3/M: -
20.93%; E4/M: -8.75%; E5/M:-18.96%; E6/M:- 35.35%), even below the 
physiological limit. (Ghergariu, 2000, Giknis, 2006), the lowest value being 
recorded at the E6 group.   625
There are a series of toxic factors that can oxidize haemoglobin or can 
interfere with the enzyme equipment, thus decreasing the energy needed by the 
endogenous oxidoreduction process and maintaining haemoglobin in a normal 
form. Hb values decrease was reported by other authors  too consecutive 
subchronic inhalation of Cr (VI), or at doses above 50 ppm (Hyeon-Yeon, 2004). 
 
Conclusions 
 
Hexavalent chromium administration in different doses and different time 
period determined decrease of globular resistance (in terms of haemolysis degree 
in hypotonic solutions) in experimental groups below the control and physiological 
values, in direct relation with the dose and duration of administration. 
By increasing the duration of administration (from 3 to 6 months), 
minimum globular resistance for equal chromium doses was not changed but 
prolonging the administration duration induced the increase of haemolysis degree 
(E4/E1 :+13.05%; E5/E2 :+22.06%; E6/E3:+15.17%). 
Managing Cr(VI) a longer period of time may cause haemolytic effect, by 
affecting erythrocyte membrane. 
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